HIGHLIGHTS
- who: David B. Dunger and collaborators from the Successful linkage of the INNODIA natural history eCRF to an interventional clinical trial has been recently achieved in the DiViDint trial (EudraCT Number:, have published the Article: STUDY PROTOCOL Master Protocol for the evaluation of investigational medicinal products in diagnosed type diabetes, in the Journal: (JOURNAL)
- what: The overall aim of INNODIA is to advance in a decisive way, how to predict, stage, evaluate and prevent the onset and progression of type 1 diabetes. The project, approved in November 2015 and launched in January 2016, runs under . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.